General principles for evaluating the abuse deterrence of generic solid oral opioid drug products
- Series Title(s):
Guidance for industry
United States. Department of Health and Human Services, issuing body.
United States. Food and Drug Administration, issuing body.
Center for Drug Evaluation and Research (U.S.), issuing body.
Silver Spring, MD : Center for Drug Evaluation and Research, November 2017
Abuse-Deterrent Formulations -- standards
Analgesics, Opioid -- administration & dosage
Investigational New Drug Application
Clinical Trials as Topic
Drug Evaluation, Preclinical
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
The National Library of Medicine believes this item to be in the public domain. (More information)
1 online resource (1 PDF file (33 pages))
- NLM Unique ID:
101719981 (See catalog record)
- Permanent Link: